Upstream clopidogrel, prasugrel, or ticagrelor for patients treated with primary angioplasty: Results of an angiographic randomized pilot study-Reference-Cited by-同舟云学术

Upstream clopidogrel, prasugrel, or ticagrelor for patients treated with primary angioplasty: Results of an angiographic randomized pilot study

Published:2015-11-28 Issue:7 Volume:87 Page:1187-1193
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Cathet. Cardiovasc. Intervent.

Author:

Mont'Alverne-Filho José R.¹²,Rodrigues-Sobrinho Carlos R.M.²,Medeiros Fernando¹²,Falcão Francisco C.²,Falcão Joao L.¹²,Silva Rafael C.³,Croce Kevin J.⁴,Nicolau Jose C.³,Valgimigli Marco⁵,Serruys Patrick W.⁵⁶,Lemos Pedro A.³

Affiliation:

1. Catheterization Laboratory, Hospital De Messejana, Dr. Carlos Alberto Studart Gomes; Fortaleza-CE Brazil

2. Department of Cardiology, Federal University of Ceara; Fortaleza-CE Brazil

3. Department of Interventional Cardiology, Heart Institute (InCor), University of São Paulo Medical School; Sao Paulo-SP Brazil

4. Brigham and Women's Hospital, Harvard Medical School; Cardiovascular Division; Boston Massachusetts

5. Department of Interventional Cardiology; Erasmus University Medical Centre, Thoraxcenter; Rotterdam The Netherlands

6. International Centre for Circulatory Health, NHLI, Imperial College London; London United Kingdom

Funder

Fundação Cearense de Apoio ao Desenvolvimento Científico e Tecnológico

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ccd.26334/fullpdf

Reference34 articles.

1. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation;Sabatine;N Engl J Med,2005

2. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: Randomised placebo-controlled trial;Chen;Lancet,2005

3. American College of Cardiology Foundation/American Heart Association Task Force on Practice G. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines;O'Gara;Circulation,2013

4. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI);Windecker;Eur Heart J,2014

5. The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting;Gurbel;J Am Coll Cardiol,2005

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of prasugrel versus ticagrelor on coronary microcirculation in patients undergoing pharmacoinvasive strategy – acute and short-term results;Coronary Artery Disease;2023-07-04

2. Ticagrelor vs. clopidogrel for coronary microvascular dysfunction in patients with STEMI: a meta-analysis of randomized controlled trials;Frontiers in Cardiovascular Medicine;2023-05-18

3. A Comparison of the Effects of Ticagrelor and Clopidogrel in Patients with Acute ST-Segment Elevation Myocardial Infarction: A systematic review and Meta-analysis;2023-02-09

4. Reperfusion Strategies in Acute Myocardial Infarction: State of the Art;International Journal of Cardiovascular Sciences;2021-05-26

5. Beneficial effect of ticagrelor on microvascular perfusion in patients with ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention;Coronary Artery Disease;2019-08